These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 3493237

  • 21. In vitro and in vivo antibacterial activities of CS-834, a novel oral carbapenem.
    Fukuoka T, Ohya S, Utsui Y, Domon H, Takenouchi T, Koga T, Masuda N, Kawada H, Kakuta M, Kubota M, Ishii C, Ishii C, Sakagawa E, Harasaki T, Hirasawa A, Abe T, Yasuda H, Iwata M, Kuwahara S.
    Antimicrob Agents Chemother; 1997 Dec; 41(12):2652-63. PubMed ID: 9420035
    [Abstract] [Full Text] [Related]

  • 22. Penicillin-binding proteins and beta-lactamases: their effects on the use of cephalosporins and other new beta-lactams.
    Neu HC.
    Curr Clin Top Infect Dis; 1987 Dec; 8():37-61. PubMed ID: 3077281
    [Abstract] [Full Text] [Related]

  • 23. The affinity of imipenem (N-formimidoylthienamycin) for the penicillin-binding proteins of Staphylococcus aureus--binding and release.
    Hashizume T, Park W, Matsuhashi M.
    J Antibiot (Tokyo); 1984 Sep; 37(9):1049-53. PubMed ID: 6334067
    [Abstract] [Full Text] [Related]

  • 24. Relation of structural properties of beta-lactam antibiotics to antibacterial activity.
    Neu HC.
    Am J Med; 1985 Aug 09; 79(2A):2-13. PubMed ID: 3895915
    [Abstract] [Full Text] [Related]

  • 25. State of penicillin-binding proteins and requirements for their bactericidal interaction with beta-lactam antibiotics in Serratia marcescens highly resistant to extended-spectrum beta-lactams.
    Gunkel AG, Hechler U, Martin HH.
    J Gen Microbiol; 1991 Feb 09; 137(2):243-52. PubMed ID: 2016583
    [Abstract] [Full Text] [Related]

  • 26. In vitro antibacterial activity of LJC 11,036, an active metabolite of L-084, a new oral carbapenem antibiotic with potent antipneumococcal activity.
    Hikida M, Itahashi K, Igarashi A, Shiba T, Kitamura M.
    Antimicrob Agents Chemother; 1999 Aug 09; 43(8):2010-6. PubMed ID: 10428928
    [Abstract] [Full Text] [Related]

  • 27. Development of resistance to beta-lactam antibiotics with special reference to third-generation cephalosporins.
    Collatz E, Gutmann L, Williamson R, Acar JF.
    J Antimicrob Chemother; 1984 Sep 09; 14 Suppl B():13-21. PubMed ID: 6334073
    [Abstract] [Full Text] [Related]

  • 28. RU 29 246, the active compound of the cephalosporin-prodrug-ester HR 916. II. Stability to beta-lactamases and affinity for penicillin-binding proteins.
    Markus A, Klesel N, Wollmann T, Isert D, Limbert M, Schrinner E, Seibert G, Bauernfeind A, Jungwirth R, Wilhelm R.
    J Antibiot (Tokyo); 1992 Apr 09; 45(4):521-6. PubMed ID: 1592684
    [Abstract] [Full Text] [Related]

  • 29. Mechanisms of resistance of enterococci to beta-lactam antibiotics.
    Fontana R, Canepari P, Lleò MM, Satta G.
    Eur J Clin Microbiol Infect Dis; 1990 Feb 09; 9(2):103-5. PubMed ID: 2180705
    [Abstract] [Full Text] [Related]

  • 30. Effect on growth curves and killing curves of brief exposure of Escherichia coli to imipenem and piperacillin.
    Yourassowsky E, Van der Linden MP, Lismont MJ, Crokaert F, Glupczynski Y.
    J Antimicrob Chemother; 1986 Dec 09; 18 Suppl E():61-5. PubMed ID: 3546248
    [Abstract] [Full Text] [Related]

  • 31. [Beta-lactam antibiotics].
    Inoue M, Okamoto R.
    Nihon Rinsho; 1990 Oct 09; 48(10):2178-83. PubMed ID: 2280461
    [No Abstract] [Full Text] [Related]

  • 32. Why are carbapenems active against Enterobacter cloacae resistant to third generation cephalosporins?
    Pechère JC.
    Scand J Infect Dis Suppl; 1991 Oct 09; 78():17-21. PubMed ID: 1658922
    [Abstract] [Full Text] [Related]

  • 33. A perspective on the present contribution of beta-lactamases to bacterial resistance with particular reference to induction of beta-lactamase and its clinical significance.
    Neu HC, Chin NX.
    Chemioterapia; 1985 Feb 09; 4(1):63-70. PubMed ID: 3872725
    [Abstract] [Full Text] [Related]

  • 34. Meropenem: activity against resistant gram-negative bacteria and interactions with beta-lactamases.
    Sanders CC, Sanders WE, Thomson KS, Iaconis JP.
    J Antimicrob Chemother; 1989 Sep 09; 24 Suppl A():187-96. PubMed ID: 2808207
    [Abstract] [Full Text] [Related]

  • 35. Impaired imipenem uptake associated with alterations in outer membrane proteins and lipopolysaccharides in imipenem-resistant Shigella dysenteriae.
    Ghosh AS, Kar AK, Kundu M.
    J Antimicrob Chemother; 1999 Feb 09; 43(2):195-201. PubMed ID: 11252324
    [Abstract] [Full Text] [Related]

  • 36. Emergence of resistance to imipenem in Pseudomonas aeruginosa.
    Lynch MJ, Drusano GL, Mobley HL.
    Antimicrob Agents Chemother; 1987 Dec 09; 31(12):1892-6. PubMed ID: 3125787
    [Abstract] [Full Text] [Related]

  • 37. Penicillin-binding proteins and induction of AmpC beta-lactamase.
    Sanders CC, Bradford PA, Ehrhardt AF, Bush K, Young KD, Henderson TA, Sanders WE.
    Antimicrob Agents Chemother; 1997 Sep 09; 41(9):2013-5. PubMed ID: 9303404
    [Abstract] [Full Text] [Related]

  • 38. Anaerobic bacteria and beta-lactam antibiotics.
    Nord CE, Olsson-Liljequist B.
    Scand J Infect Dis Suppl; 1984 Sep 09; 42():72-82. PubMed ID: 6335601
    [Abstract] [Full Text] [Related]

  • 39. Comparison of two carbapenems, SM-7338 and imipenem: affinities for penicillin-binding proteins and morphological changes.
    Sumita Y, Fukasawa M, Okuda T.
    J Antibiot (Tokyo); 1990 Mar 09; 43(3):314-20. PubMed ID: 2108953
    [Abstract] [Full Text] [Related]

  • 40. [Mechanism of susceptibility and resistance of bacteria to beta-lactam antibiotics].
    Tsuji A.
    Nihon Rinsho; 1991 Oct 09; 49(10):2254-60. PubMed ID: 1749080
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.